The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | An insight into familial myeloma
Meral Beksac, MD, PhD, Ankara University, Ankara, Turkey, briefly discusses familial myeloma and two recent abstracts that were presented at the last meeting of the International Myeloma Society (IMS). Prof. Beksac shares some insights into the occurrence of familial myeloma and emerging data in this field, as well as another abstract investigating natural killer (NK) cell haplotypes and the expansion of this research. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
